Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
27 October 2016 16:50 ASTRAZENECA HEAD AND NECK CANCER TRIALS Following the recent update on clinicaltrials.gov, AstraZeneca confirms that the US FDA has placed a partial clinical hold on the...
-
This announcement contains inside information 26 October 2016 07:00 LYNPARZA PHASE III SOLO-2 TRIAL SHOWS SIGNIFICANT PROGRESSION-FREE SURVIVAL BENEFIT Trial studied Lynparza as maintenance...
-
18 October 2016 [07:00] AstraZeneca today announced that the US Food and Drug Administration (FDA) has accepted a complete re-submission of a New Drug Application (NDA) for sodium zirconium...
-
This announcement contains inside information 4 October 2016 07:05 ASTRAZENECA ENTERS AGREEMENT WITH ARALEZ FOR BETA-BLOCKER MEDICINE TOPROL-XL IN THE US AstraZeneca today announced that it has...
-
This announcement contains inside information 04 October 2016 07:00 ASTRAZENECA REPORTS TOP-LINE RESULTS FROM THE BRILINTA EUCLID TRIAL IN PATIENTS WITH PERIPHERAL ARTERY DISEASE Brilinta did not...
-
3 October 2016 15:00 Transparency Directive Voting Rights and Capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule...
-
This announcement contains inside information 03 October 2016 07:00 AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a licensing...
-
28 September 2016 07:00 CHANGE TO ASTRAZENECA BOARD OF DIRECTORS AstraZeneca today announced that Dr Cornelia (Cori) Bargmann, a Non-Executive Director, will step down from the Board of AstraZeneca...
-
26 September 2016 16:00 Transaction by Person Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 On 26 September 2016, the interest of Sean Bohen, a person discharging managerial...
-
22 September 2016 11.00 New external board appointment Listing Rule LR 9.6.14 R (2) Ann Cairns, a Non-Executive Director of AstraZeneca PLC, is expected to join the Board of Directors of...